SG

Subhash Gupta

Active Director Director DIN 11218989
DIN 11218989 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Subhash Gupta

Data last updated:

Subhash Gupta is a Director at Amrad Healthcare Private Limited (since 2025). The company operates in Healthcare. Amrad Healthcare Private Limited reported revenue of ₹4.12 Cr (FY 2025).

DIN 11218989
Primary Designation Director
Industry Healthcare
First Appointment 27 Jul 2025
Oldest Company Age 4 yrs
Largest company Amrad Healthcare Private Limited · ₹4.12 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amrad Healthcare Private Limited U33309DL2022PTC396203
Director27 Jul 20252022₹4.12 Cr (FY 2025)Active

Board colleagues of Subhash Gupta

Directorship timeline

Open interactive timeline →
Amrad Healthcare Private Limited
Premium access

Shareholding and investment profile for Subhash Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Gupta

Subhash Gupta currently holds 1 directorship: Amrad Healthcare Private Limited (Director, since 27 Jul 2025, revenue ₹4.12 Cr (FY 2025)).

Subhash Gupta was first appointed on 27 Jul 2025 as Director at Amrad Healthcare Private Limited.

The current boards of Subhash Gupta's companies include Girish Kumar Sadana (Amrad Healthcare Private Limited), Sarwesh Nandan (Amrad Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available